Acadia Healthcare Company Inc. (NASDAQ:ACHC) experienced a significant after-hours plunge of 13.34% following the release of its fourth-quarter 2024 financial results and full-year 2025 outlook. The healthcare company, which provides behavioral healthcare services across the United States and Puerto Rico, reported mixed results that fell short of analyst expectations.
In the fourth quarter, Acadia Healthcare generated revenue of $774.238 million, missing the consensus estimate of $779 million. Additionally, the company's adjusted EBITDA of $153.1 million fell short of the expected $171.4 million. Despite these misses, the company reported net income of $33.529 million for the quarter.
Looking ahead, Acadia Healthcare provided guidance for the full year 2025 that may have disappointed investors. The company expects revenue in the range of $3.3 billion to $3.4 billion and adjusted EBITDA between $675 million and $725 million. Furthermore, Acadia Healthcare anticipates capital expenditures ranging from $525 million to $575 million as it continues to invest in expanding its psychiatric bed capacity to meet the growing demand for mental health services.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。